Skip to content

Clinical utility of synthesis 9.1 repertory in women suffering from urinary tract infection

Clinical utility of synthesis 9.1 repertory in cases of urinary tract infection in women using visual analog scale (vas) for uti symptom assessment. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/096014
Enrollment
50
Registered
2025-10-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N390- Urinary tract infection, site notspecified

Interventions

Intervention1: Individualized homeopathic medicine: The medicine will be prescribed after repertorising the case with help of synthesis 9.1 repertory the final choice will be made with the aid of mate

Sponsors

Deepika Brijendrakumar Shrivastav
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Women aged 18-65 with urinalysis suggestive of at least 10 raise to 5 CFU/mL with symptomatic presentation presenting with symptoms of uncomplicated urinary tract infection within the past 48 hours able to give informed consent. 2 Patients who are willing to continue the treatment and follow-up according to protocol. 3 Female of all socioeconomic condition will be considered Patients willing to participate in study for their acute urinary tract infection will be considered. 4 Patients with recurrent cases of urinary tract infection.

Exclusion criteria

Exclusion criteria: 1 Pregnant women, individuals with diabetes or kidney disease, those currently on antibiotics, and those patients where urinary tract infection is due to underlying advance pathology. 2 Patient suffering from any other systemic diseases like renal disease or other pathology. Catheter induced urinary tract infection will be excluded in this study.

Design outcomes

Primary

MeasureTime frame
Based on visual analog scale for utiTimepoint: At the baseline and at the end of each follow-ups

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactDr Abhishek Udani

Anand Homoeopathic Medical College and Research Institute

udaniabhishek@gmail.com9978624694

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026